Meet the Editorial Board Member-Reference-Cited by-同舟云学术

Meet the Editorial Board Member

Published:2021-08-24 Issue:3 Volume:17 Page:171-172
ISSN:1573-3947
Container-title:Current Cancer Therapy Reviews
language:en
Short-container-title:CCTR

Author:

Friedman Henry S.¹

Affiliation:

1. Duke University Medical Center Durham, NC, United States

Abstract

Publisher

Bentham Science Publishers Ltd.

Subject

Cancer Research,Oncology,Molecular Medicine

Reference15 articles.

1. Friedman H.S.; Burger P.C.; Bigner S.H.; Trojanowski J.; Halperin E.C.; Bigner D.D.; Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283. Med J Neuropathol Exp Neurol 1985,44,592-605

2. Friedman H.S.; Burger P.C.; Bigner S.H.; Trojanowski J.Q.; Brodeur G.M.; He X.; Wikstrand C.J.; Kurtzberg J.; Berens M.; Halperin E.C.; Bigner D.D.; Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc. Am J Pathol 1988,130,472-484

3. Friedman H.S.; Colvin O.M.; Skapek S.X.; Ludeman S.M.; Elion G.B.; Schold S.C.; Jacobsen P.F.; Muhlbaier L.H.; Bigner D.D.; Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents. Cancer Res 1988,48,4189-4195

4. Friedman H.S.; Schold S.C.; Mahaley M.S.; Colvin O.M.; Oakes W.J.; Vick N.A.; Burger P.C.; Bigner S.H.; Borowitz M.; Halperin E.C.; Djang W.; Falletta J.M.; deLong R.; Garvin J.H.; DeVivo D.C.; Norris D.; Golumbe B.; Winter J.; Bodziner R.A.; Sipahi H.; Bigner D.D.; Phase II treatment of medulloblastoma and pineoblastoma with melphalan: Clinical therapy based on experimental models of human medulloblastoma. J Clin Oncol 1989,7,904-911

5. Friedman H.S.; Colvin O.M.; Kaufman S.H.; Ludeman S.M.; Bullock N.; Bigner D.D.; Griffith O.W.; Cyclophosphamide resistance in medulloblastoma. Cancer Res 1992,52,5373-5378